Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
about
Interventions for dialysis patients with hepatitis C virus (HCV) infectionManagement of chronic hepatitis C virus infection in patients with end-stage renal disease: a reviewHepatitis C infection in hemodialysis patients: A reviewInterferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological ResponseDiagnosis, management, and treatment of hepatitis C: an updateIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Management of hepatitis C in patients with chronic kidney disease.Hepatitis C and kidney transplantationHepatitis C in hemodialysis patientsEfficacy and safety of treatment of hepatitis C virus infection in renal transplant recipientsTreatment of HCV patients before and after renal transplantation.[Are HVC patients on hemodialysis really difficult to treat patients?].Hepatitis C virus infection in dialysis patients.Hepatitis C in dialysis units: the Saudi experience.HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirinTreatment of chronic hepatitis C in hemodialysis patients.Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.Treatment of hepatitis C virus infection in patients with end-stage renal disease.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.Hepatitis C infection and chronic renal diseases.Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience.Viral hepatitis in solid organ transplantation.Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.Should ribavirin be used to treat hepatitis C in dialysis patients?Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
P2860
Q24187826-8EB5CD4D-FD22-4281-82A5-2184EDFD8665Q26821786-78C961B8-F341-456F-BDB4-627E59A0F4E8Q27009100-E7F9C03A-6757-4C1A-BA2B-794A139F2150Q27489433-656F2513-6B96-43A5-950D-76BE9ABFF38EQ29619682-147412F0-5B78-408E-AB77-6E55B97ACDA6Q30375305-B0297FF3-28FB-4CE4-907E-C2780C23B69AQ30417045-89436877-B2FD-4621-84F1-83637D65B278Q33374217-902C129D-09BD-4487-8F2F-B94D0B573521Q33969758-982519E8-E86D-4B1E-9938-6919BC01853BQ34932338-3DE11456-5A30-4040-8944-FAE90BC55576Q35094769-A42B4493-8939-4530-90A9-B08D9167C4DFQ35237329-DFB5D65F-ECBC-42F3-A0E5-4AC94C5A4C98Q35653600-E27DAD18-9E07-4EA6-9D3E-B6F074603A46Q35714749-E95709AF-86F4-48C7-8C6C-454786F0A184Q36680222-E7B7F800-766E-4503-ACFC-494156997E3DQ36852114-B52A77E6-E27C-4481-91C2-99845C1BD049Q36852123-BE309F09-7DDC-4C2F-A5E0-005A4AA7B66CQ37025954-F104BA49-E87F-4C8E-BEA0-83E1BD512605Q37313163-F0DD4782-9158-4616-8644-EC66DC8B7356Q37812399-F706238F-2C1F-4C69-96B4-058419804E8EQ37831965-7FB9EC86-B41C-4599-B10E-45481B1BF896Q38213956-89F62A21-8031-43F6-9092-1D0248BE5891Q38231457-F50C6170-85DD-4408-9A66-3F9C34B24819Q38552198-3E16BC82-EDDC-4723-94F7-D32E45E365ACQ42267579-5DA35CFE-DBE3-40D2-9626-A3161B00ED7DQ42272319-4C12310F-447C-455D-96CC-EAAB18A4B2F7Q42997177-9DA3D1D6-1EBA-4B73-AB34-ADB735C67893Q42999273-6236AB2F-C234-4E85-A245-78F5CA33AFF3Q45867154-75D318BE-0C1A-4B8F-8457-897A988B8BFAQ50556069-A272DA3F-A9EA-4FD7-A5A6-F6327124E48D
P2860
Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@en
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@nl
type
label
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@en
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@nl
prefLabel
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@en
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@nl
P2093
P1476
Alpha-interferon with ribaviri ...... sis patients with hepatitis C.
@en
P2093
Abdalla AH
Al-Hawas FA
Al-Khader AA
Al-Shoail G
Al-Sulaiman MH
P304
P356
10.1016/J.TRANSPROCEED.2004.07.025
P407
P577
2004-07-01T00:00:00Z